Mesalazine-associated tubulo-interstitial nephritis in inflammatory bowel disease

Clinical Nephrology

Volumn 49, Issue 4, 1998, Pages 265-267

  Calvino J ^a   Romero, R ^a   Pintos, E ^a   Losada, E ^a   Novoa, D ^a   Guimil D ^a   Mardaras, J ^a   Sanchez Guisande, D ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Inflammatory bowel disease; Interstitial nephritis; Mesalazine; Renal failure

Indexed keywords

MESALAZINE; STEROID;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CROHN DISEASE; DISEASE COURSE; ENTERITIS; FEMALE; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY FAILURE; KIDNEY FUNCTION; ORAL DRUG ADMINISTRATION; PATIENT MONITORING;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CROHN DISEASE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOCORTICOIDS; HUMANS; KIDNEY; MESALAMINE; NEPHRITIS, INTERSTITIAL; PREDNISONE; TIME FACTORS;

EID: 0031919795     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Austin CA, Cann PA, Jones TH, Holdsworth CD 1984 Exacerbation of diarrhoea and pain in patients treated with 5-aminosalicylic acid for ulcerative colitis. Lancet 1: 917-918
2. Clive DM, Stoff JF 1984 Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 310: 563-572
3. Daneshmend TK 1991 Mesalazine-associated thrombocytopenia. Lancet 1: 1297-1298
4. Dawarakanath AD, Michael J, Allan RN 1992 Sulphasalazine induced renal failure. Gut 33: 1006-1007
5. Garcia-Diaz M, Nevado L, Berenger A et al. 1995 Insuficiencia renal aguda asociada a acido 5-aminosalicilico en la enfermedad inflamatoria intestinal. Gastroenterol Hepatol 18: 27-31
6. Greenstein A 1992 Amyloidosis and inflammatory bowel disease: A 50-year experience with 25 patients. Medicine 71: 261
7. Laursen LS, Stokholm M, Buckhave K, Rask-Madsen J, Lauritsen K 1990 Disposition of 5-aminosalicylic acid by olsalazine and the three ,mesalazine preparations in patients with ulcerative colitis. Gut 31: 1271-1276
8. Lichtenstein GR 1993 Medical therapies for inflammatory bowel disease. Curr Opin Gastroenterol 9: 588-599
9. Mahmud N, Stinson J, O'Connell MA et al. 1994 Microalbuminuria in inflammatory bowel disease. Gut 35: 1599-1604
10. Masson EA, Rhodes JM 1992 Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss. Gut 33: 563-564
11. Novis BM, Korzets Z, Chen P, Berheim J 1988 Nephrotic syndrome after treatment with 5-aminosalicylic acid. B Med J 296: 1442
12. Riley SA, Lloyd DR, Mani V 1992 Test of renal function in patients with quiescent colitis. Gut 33: 1348-1352
13. Riley SA, Mani V, Goodman J. Herd ME, Dutt S, Turnberg LA 1988 Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis. Gastroenterology 94: 1383-1389
14. Simmonds NJ, Rampton DS 1993 Inflammatory bowel disease - A radical review. Gut 34: 865-868
15. Smilde TJ et al. 1994 Tubulointerstitiale nefritis door mesalazine (5-ASA) preparaten. Ned Tijdschr Geneeskd 138: 2557-2561
16. Thomas DM, Nicholls AJ, Feest TG 1990 Ulcerative colitis and glomerulonephritis: Is there an association? Nephrol Dial Transplant 5: 628-629
17. Thuluvath PJ, Ninkovic M, Calam J, Anderson M 1994 Mesalazine induced interstitial nephritis. Gut 35: 1493-1496
18. World MJ, Stevens PE et al. 1996 Mesalazine-associated interstitial nephritis. Nephrol Dial Transplant 11: 614-621